Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2009

01.01.2009 | Original Article

The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors

verfasst von: Tayfun Gungor, Mine Kanat-Pektas, Ayhan Sucak, Leyla Mollamahmutoglu

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Thrombocytosis has been reported in a variety of solid tumors, including certain gynecologic cancers such as endometrial, vulvar, and cervical cancers. The present study aims to determine the incidence of thrombocytosis in women with epithelial ovarian tumors and to evaluate its association with clinical and pathologic prognostic factors.

Material and methods

Between January 2001 and December 2006, 292 patients were diagnosed with epithelial ovarian tumors, and they underwent primary surgical treatment and subsequent platinum-based chemotherapy at the Gynecologic Oncology Department of the study center. The medical records of these patients were evaluated retrospectively.

Results

Of the 292 women with epithelial ovarian tumors undergoing primary surgical exploration, 124 (42.5%) had thrombocytosis, indicating platelet counts >400 × 109/l. Patients with thrombocytosis were found to have statistically higher levels of preoperative CA-125 levels, more advanced stage disease, higher grade tumors, and shorter periods of survival. Thrombocytosis is a significant negative prognostic factor for survival in patients with epithelial ovarian tumors.

Conclusions

Thrombocytosis is frequently detected in preoperative evaluation of women diagnosed with epithelial ovarian tumors. The data obtained by the previous and present studies suggest that thrombocytosis is associated with factors reflecting a more aggressive tumor biology, and predicting poor survival in women with epithelial ovarian tumors. However, these data are limited by the retrospective nature of the studies and do not confirm a casual relationship between thrombocytosis and tumor behavior. Molecular studies investigating the expression of platelet secretory factors are required to clarify the differences among data provided by the literature.
Literatur
1.
Zurück zum Zitat Amoletti JP, Albo D, Granick MS, Solomon MP, Castiglioni A, Rothman VL et al (1995) Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76:998–1005CrossRef Amoletti JP, Albo D, Granick MS, Solomon MP, Castiglioni A, Rothman VL et al (1995) Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76:998–1005CrossRef
2.
Zurück zum Zitat Benoy I, Salgado R, Colpaert C, Weytjens R (2002) Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2:311–315CrossRefPubMed Benoy I, Salgado R, Colpaert C, Weytjens R (2002) Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2:311–315CrossRefPubMed
3.
Zurück zum Zitat Chalas E, Welshinger M, Engellener W, Chumas J, Barbieri R, Mann WJ (1992) The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 166:974–977CrossRefPubMed Chalas E, Welshinger M, Engellener W, Chumas J, Barbieri R, Mann WJ (1992) The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 166:974–977CrossRefPubMed
4.
Zurück zum Zitat Constantini V, Zacharski LR, Moritz TE, Edwards RL (1990) The platelet count in carcinoma of the lung and colon. Thromb Haemost 64:501–505 Constantini V, Zacharski LR, Moritz TE, Edwards RL (1990) The platelet count in carcinoma of the lung and colon. Thromb Haemost 64:501–505
5.
Zurück zum Zitat Dabrow MB, Francesco MR, McBrearty FX, Caradonna S (1998) The effect of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol Oncol 71:29–37CrossRefPubMed Dabrow MB, Francesco MR, McBrearty FX, Caradonna S (1998) The effect of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol Oncol 71:29–37CrossRefPubMed
6.
Zurück zum Zitat Friebe Z, Watrowski R, Bembnista M, Rokowska A, Wlosiinska J (2005) Correlation between platelet count and CA–125 in ovarian cancer. Ginekol Pol 76(3):187–194PubMed Friebe Z, Watrowski R, Bembnista M, Rokowska A, Wlosiinska J (2005) Correlation between platelet count and CA–125 in ovarian cancer. Ginekol Pol 76(3):187–194PubMed
7.
Zurück zum Zitat Gastl G, Plante M, Finstad CL, Wong GY, Federici MG, Bander NH et al (1993) High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 83:433–441CrossRefPubMed Gastl G, Plante M, Finstad CL, Wong GY, Federici MG, Bander NH et al (1993) High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 83:433–441CrossRefPubMed
8.
Zurück zum Zitat Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C et al (2000) Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21:309–314CrossRefPubMed Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C et al (2000) Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21:309–314CrossRefPubMed
9.
Zurück zum Zitat Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB (2000) The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 78:137–142CrossRefPubMed Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB (2000) The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 78:137–142CrossRefPubMed
10.
Zurück zum Zitat Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9:287–291CrossRefPubMed Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9:287–291CrossRefPubMed
11.
Zurück zum Zitat Kerpsack JT, Finan MA (2000) Thrombocytosis as a predictor of malignancy in women with a pelvic mass. J Reprod Med 45:929–932PubMed Kerpsack JT, Finan MA (2000) Thrombocytosis as a predictor of malignancy in women with a pelvic mass. J Reprod Med 45:929–932PubMed
12.
Zurück zum Zitat Levin J, Conley CL (1964) Thrombocytosis associated with malignant disease. Arch Int Med 114:497–500CrossRef Levin J, Conley CL (1964) Thrombocytosis associated with malignant disease. Arch Int Med 114:497–500CrossRef
13.
Zurück zum Zitat Li AJ, Madden CM, Cass I, Leuchter RS, Lagasse LD (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92:211–214CrossRefPubMed Li AJ, Madden CM, Cass I, Leuchter RS, Lagasse LD (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92:211–214CrossRefPubMed
14.
Zurück zum Zitat Menczer J, Schejter E, Geva D, Ginath S (1998) Ovarian carcinoma associated thrombocytosis: correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 12:82–84 Menczer J, Schejter E, Geva D, Ginath S (1998) Ovarian carcinoma associated thrombocytosis: correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 12:82–84
15.
Zurück zum Zitat O’Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA (2002) Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 168:1378–1380CrossRefPubMed O’Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA (2002) Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 168:1378–1380CrossRefPubMed
16.
Zurück zum Zitat Pedersen LM, Milman N (2003) Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep 10:213–216PubMed Pedersen LM, Milman N (2003) Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep 10:213–216PubMed
17.
Zurück zum Zitat Qian X, Tuszynski GP (1996) Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med 212:199–207CrossRefPubMed Qian X, Tuszynski GP (1996) Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med 212:199–207CrossRefPubMed
18.
Zurück zum Zitat Scholz HS, Petru E, Gucer F, Haas J (2000) Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20:3983–3985PubMed Scholz HS, Petru E, Gucer F, Haas J (2000) Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20:3983–3985PubMed
19.
Zurück zum Zitat Schwarz RE, Keny H (2001) Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Hepatogastroenterology 48:1493–1498PubMed Schwarz RE, Keny H (2001) Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Hepatogastroenterology 48:1493–1498PubMed
20.
Zurück zum Zitat Soonthornthum T, Suraseraneewong V, Kengsakol K, Wijaithum K (2007) Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thai 90(8):1495–1500PubMed Soonthornthum T, Suraseraneewong V, Kengsakol K, Wijaithum K (2007) Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thai 90(8):1495–1500PubMed
21.
Zurück zum Zitat Tamussino KF, Gucer F, Reich O, Moser F, Petru E (2001) Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer 11:236–240CrossRefPubMed Tamussino KF, Gucer F, Reich O, Moser F, Petru E (2001) Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer 11:236–240CrossRefPubMed
22.
Zurück zum Zitat Zeimet AG, Marth C, Muller-Holzmer E, Daxenbichler G (1994) Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170:549–554CrossRefPubMed Zeimet AG, Marth C, Muller-Holzmer E, Daxenbichler G (1994) Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170:549–554CrossRefPubMed
Metadaten
Titel
The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors
verfasst von
Tayfun Gungor
Mine Kanat-Pektas
Ayhan Sucak
Leyla Mollamahmutoglu
Publikationsdatum
01.01.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-008-0673-9

Weitere Artikel der Ausgabe 1/2009

Archives of Gynecology and Obstetrics 1/2009 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.